Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Aspirin55 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00053 | 35242045 | Front Physiol | Feasibility, Efficacy, and Safety of Percutaneous Muscle Biopsies in Patients With Chronic Liver Disease. | 2022 | Details |
| A00554 | 35048107 | Eur Heart J | Polypill for prevention of cardiovascular diseases with focus on non-alcoholic steatohepatitis: the PolyIran-Liver trial. | 2022 | Details |
| A01271 | 34806071 | Lancet Reg Health Eur | Antithrombotic therapy in patients with liver disease: population-based insights on variations in prescribing trends, adherence, persistence and impact on stroke and bleeding. | 2021 | Details |
| A02532 | 34339764 | J Hepatol | Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention. | 2021 | Details |
| A05147 | 33354924 | Basic Clin Pharmacol Toxicol | The effect of acetylsalicylic acid and pentoxifylline in guinea pigs with non-alcoholic steatohepatitis. | 2021 | Details |
| A05716 | 33144054 | Dig Liver Dis | Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population. | 2020 | Details |
| A06962 | 32685690 | Hepatoma Res | Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma. | 2020 | Details |
| A08073 | 32258142 | Biomed Res Int | Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPARδ-AMPK-PGC-1α Pathway in Dyslipidemic Conditions. | 2020 | Details |
| A08201 | 32207583 | Adv Clin Exp Med | Advanced glycation end products derived from serum albumin modification by glucose (AGE-1) reflect clustering of lipid-associated metabolic abnormalities and are decreased in patients treated with acarbose: A cross-sectional study. | 2020 | Details |
| A09276 | 31808577 | Hepatology | Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD. | 2020 | Details |
| A11027 | 31077838 | Clin Gastroenterol Hepatol | Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11327 | 30936549 | Nat Med | Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. | 2019 | Details |
| A12382 | 30476583 | Clin Gastroenterol Hepatol | Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study. | 2018 | Details |
| A12513 | 30413815 | Lab Invest | Sex-associated preventive effects of low-dose aspirin on obesity and non-alcoholic fatty liver disease in mouse offspring with over-nutrition in utero. | 2018 | Details |
| A13237 | 30070430 | Mol Nutr Food Res | Soyasaponins Reduce Inflammation and Improve Serum Lipid Profiles and Glucose Homeostasis in High Fat Diet-Induced Obese Mice. | 2018 | Details |
| A13758 | 29771124 | J Agric Food Chem | Genistein Ameliorates Non-alcoholic Fatty Liver Disease by Targeting the Thromboxane A2 Pathway. | 2018 | Details |
| A16196 | 28509327 | Int J Cancer | The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease. | 2017 | Details |
| A17079 | 28002874 | J Gastroenterol Hepatol | High serum alanine aminotransferase is associated with the risk of colorectal adenoma in Korean men. | 2017 | Details |
| A17298 | 27859470 | Aliment Pharmacol Ther | Non-alcoholic fatty liver diseases and risk of colorectal neoplasia. | 2016 | Details |
| A18392 | 27166128 | Am J Gastroenterol | Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study. | 2016 | Details |
| A19118 | 26749582 | Aliment Pharmacol Ther | Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. | 2016 | Details |
| A19920 | 26265520 | Arch Iran Med | PolyPill for Prevention of Cardiovascular Disease in an Urban Iranian Population with Special Focus on Nonalcoholic Steatohepatitis: A Pragmatic Randomized Controlled Trial within a Cohort (PolyIran - Liver) - Study Protocol. | 2015 | Details |
| A20775 | 25742316 | Biochem J | Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity. | 2015 | Details |
| A21623 | 25176122 | Aliment Pharmacol Ther | Association between aspirin use and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey. | 2014 | Details |
| A23520 | 23714479 | Am Soc Clin Oncol Educ Book | How do mechanisms of hepatocarcinogenesis (HBV, HCV, and NASH) affect our understanding and approach to HCC? | 2013 | Details |
| A25190 | 22105182 | J Clin Gastroenterol | Coronary artery stents and antiplatelet therapy in patients with cirrhosis. | 2012 | Details |
| A25294 | 21987620 | World J Gastroenterol | JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. | 2011 | Details |
| A25790 | 21453696 | Eur J Pharmacol | Nitro-aspirin is a potential therapy for non alcoholic fatty liver disease. | 2011 | Details |
| A27348 | 18596193 | Gut | Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. | 2008 | Details |
| A27764 | 17491541 | Ir Med J | Recurrence of Kawasaki disease in an adult patient with cholecystitis. | 2007 | Details |
| A28180 | 16225469 | Aliment Pharmacol Ther | Review article: the metabolic syndrome and non-alcoholic fatty liver disease. | 2005 | Details |
| A29930 | 33255794 | J Clin Med | Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges. | 2020 | Details |
| A33000 | 26885230 | Int J Clin Exp Med | Preclinical analysis of nonsteroidal anti-inflammatory drug usefulness for the simultaneous prevention of steatohepatitis, atherosclerosis and hyperlipidemia. | 2015 | Details |
| A33779 | 25169677 | Neurobiol Aging | Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis. | 2014 | Details |
| A34863 | 22403205 | J Am Board Fam Med | Navigating change: how outreach facilitators can help clinicians improve patient outcomes. | 2012 | Details |
| A35862 | 19544392 | Glia | Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. | 2010 | Details |
| A36345 | 18397235 | Liver Int | Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. | 2008 | Details |
| A37990 | 12580974 | Br J Haematol | Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (Beta2GPI) polymorphism and anti-Beta2GPI antibodies. | 2003 | Details |
| A42929 | 33053354 | Cell Rep | Prostaglandin E2-EP4 Axis Promotes Lipolysis and Fibrosis in Adipose Tissue Leading to Ectopic Fat Deposition and Insulin Resistance. | 2020 | Details |
| A43345 | 31937400 | Clin Gastroenterol Hepatol | Daily Aspirin Use Associated With Reduced Risk for Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43585 | 31352095 | Clin Gastroenterol Hepatol | Reply. | 2019 | Details |
| A43629 | 31252189 | Clin Gastroenterol Hepatol | Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug. | 2019 | Details |
| A45263 | 25483431 | Aliment Pharmacol Ther | Editorial: would an aspirin a day keep NAFLD and its complications away? | 2015 | Details |
| A45831 | 22487461 | Dig Liver Dis | If steatosis is the atherosclerosis of the liver, are statins the "aspirin" for steatosis? | 2012 | Details |
| A46705 | 16361039 | Clin Gastroenterol Hepatol | GIH clinical research update: 2004-2005. | 2005 | Details |
| A46808 | 15151470 | Expert Rev Cardiovasc Ther | Treatment of metabolic syndrome. | 2004 | Details |
| A46899 | 10811531 | Cell Biol Toxicol | Hepatotoxicity due to mitochondrial dysfunction. | 1999 | Details |
| A47050 | 27861855 | Int J Cancer | Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study. | 2016 | Details |
| A47531 | 2873160 | J Am Coll Nutr | Control of polyunsaturated acids in tissue lipids. | 1986 | Details |
| A47651 | 34247393 | Aliment Pharmacol Ther | Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma. | 2021 | Details |
| A47871 | 30534594 | Transplant Direct | Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management. | 2018 | Details |
| A50639 | 35318571 | Indian J Gastroenterol | Antiplatelet therapy associated with lower prevalence of advanced liver fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2022 | Details |
| A50667 | 35308229 | Front Pharmacol | Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies. | 2022 | Details |
| A51646 | 35292606 | Gut Liver | Osteoporosis Is Associated with an Increased Risk of Colorectal Adenoma and High-Risk Adenoma: A Retrospective, Multicenter, Cross-Sectional, Case-Control Study. | 2022 | Details |
| A52768 | 22276255 | Indian J Endocrinol Metab | Metabolic syndrome in the Mediterranean region: Current status. | 2012 | Details |